Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
- 1 September 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 154 (3), 1096-1099
- https://doi.org/10.1016/s0022-5347(01)66985-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Short-term freedom from disease progression after I-125 prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- Brachytherapy and organ preservation in the management of carcinoma of the prostateSeminars in Radiation Oncology, 1993
- Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostateUrology, 1993
- A CT-based evaluation method for permanent implants: application to prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate CancerJournal of Urology, 1992
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Transperineal 125 Iodine Seed Implantation in Prostatic Cancer Guided by Transrectal UltrasonographyJournal of Urology, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- RADIUM IN THE TREATMENT OF CARCINOMA OF THE BLADDER AND PROSTATEJAMA, 1917